ArticleJournal of pharmaceutical policy and practice2025

Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus.

Laila Carolina Abu Esba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.